General principles involved in management of poisoning- by rxvichu!!RxVichuZ
Hellow friends!!! I am back....with my 13th ppt!!
This ppt is regarding TOXICOLOGY,which happens to be my 1st....and i am happy to release the same on INDEPENDENCE DAY!!
Wishing a very happy and blissful Independence Day to all....i release my toxicology ppt regarding GENERAL PRINCIPLES IN POISONING MANAGEMENT.....
Since its my 1st attempt in Toxicology, i would love to hear ur reviews, and comments....so that i can improve in upcoming editions......
Keep reading...thanks for ur support!!!
With love and regards,
Vishnu.R.Nair (rxvichu-alwz4uh!!)
:) :)
discuss about the need for pediatric pharmacists. explains about the pharmacological and physiological factors such as dose of drug, dosage forms, weight of child, age of child, BSA of child that have to be considered on prescribing a pediatric patient
Introduction to dosage regimen and Individualization of dosage regimenKLE College of pharmacy
Introduction of Dosage regimen, Approaches for design of dosage regimen, Individualization, Advantages, Dosage in neonates, Geriatrics, Renal and Hepatic impaired Patients.
DRUG DOSAGE CALCULATION IN PEDIATRICS BY MANISHA THAKURManisha Thakur
DRUG DOSAGE CALCULATION IN PEDIATRICS:
PEDIATRIC DOSAGE DIFFERENT FROM ADULTS
FORMULAS: YOUNG, CLARK, DILLING, FRIED RULES
BASED ON AGE, BASED ON BODY SURFACE AREA, WEIGHT
EXAMPLES.
DRUG DOSAGE CALCULATION
DAILY FLUID REQUIREMENT
CALCULATION OF DRIP RATE
INFUSION PUMP FLOW RATE CALCULATION.
General principles involved in management of poisoning- by rxvichu!!RxVichuZ
Hellow friends!!! I am back....with my 13th ppt!!
This ppt is regarding TOXICOLOGY,which happens to be my 1st....and i am happy to release the same on INDEPENDENCE DAY!!
Wishing a very happy and blissful Independence Day to all....i release my toxicology ppt regarding GENERAL PRINCIPLES IN POISONING MANAGEMENT.....
Since its my 1st attempt in Toxicology, i would love to hear ur reviews, and comments....so that i can improve in upcoming editions......
Keep reading...thanks for ur support!!!
With love and regards,
Vishnu.R.Nair (rxvichu-alwz4uh!!)
:) :)
discuss about the need for pediatric pharmacists. explains about the pharmacological and physiological factors such as dose of drug, dosage forms, weight of child, age of child, BSA of child that have to be considered on prescribing a pediatric patient
Introduction to dosage regimen and Individualization of dosage regimenKLE College of pharmacy
Introduction of Dosage regimen, Approaches for design of dosage regimen, Individualization, Advantages, Dosage in neonates, Geriatrics, Renal and Hepatic impaired Patients.
DRUG DOSAGE CALCULATION IN PEDIATRICS BY MANISHA THAKURManisha Thakur
DRUG DOSAGE CALCULATION IN PEDIATRICS:
PEDIATRIC DOSAGE DIFFERENT FROM ADULTS
FORMULAS: YOUNG, CLARK, DILLING, FRIED RULES
BASED ON AGE, BASED ON BODY SURFACE AREA, WEIGHT
EXAMPLES.
DRUG DOSAGE CALCULATION
DAILY FLUID REQUIREMENT
CALCULATION OF DRIP RATE
INFUSION PUMP FLOW RATE CALCULATION.
Critical evaluation of biomedical literature - clinical pharmacyShaistaSumayya
Reviewing the ‘Biomedical Literature’ poses a great challenge to the clinical professionals.
Evaluating a scientific article is a complex task.
Knowledge of the standard anatomy of an article and idiosyncrasy of various types of studies will assist the reader to review the ‘Biomedical Literature’ efficiently
Biomedical Literature includes critical appraisal of the following contents:
Title
Abstract
Introduction
Objective
Materials and Methods
Study Designs
Bias
Statistics
Results and Analysis
Discussion and Conclusion
References
Home remedies and patient counselling tips for ANEMIA-By rxvichu-alwz4uh!! :) :)RxVichuZ
Hello members....this is my 28th powerpoint..on exactly half of the date(14.09.2017)...lol
This presentation of mine, centralizes on ANEMIA, its introduction, causes, manifestations, and includes GENEROUS DETAILS, on 15 HOME REMEDIES, along with PATIENT COUNSELLING TIPS(DO'S and DONT'S).
This will surely be helpful for those who are studying about ANEMIA, those who indulge in patient counselling, and those who wish to read it for general reference purpose.
I am self-specializing in HOME REMEDY STUDY, and PATIENT COUNSELLING. So, for further details, you can also contact me.
Reviews, suggestions, and critical evaluations, are ALWAYS WELCOME!!
Regards,
Vishnu.R.Nair,
5th year Pharm.D,
National College of Pharmacy, Kerala, India.
In this slides included clinical pharmacy introduction and pharmaceutical care, also explanation about the goals and objectives of the clinical pharmacy requirements
Individualisation and optimization of drug dosing regimenJyoti Nautiyal
Drug dosing regimen, dosing frequency, individualisation, Steps Involved in Individualization of Dosage Regimen, optimization, variability, Clinical experience with individualization and optimization based on plasma drug levels.
Pediatric Drug calculations |drug calculation formulasNEHA MALIK
Most drugs in children are dosed according to body weight (mg/kg) or body surface area (BSA) (mg/m2). Care must be taken to properly convert body weight from pounds to kilograms (1 kg= 2.2 lb) before calculating doses based on body weight. Doses are often expressed as mg/kg/day or mg/kg/dose, therefore orders written "mg/kg/d," which is confusing, require further clarification from the prescriber.
Critical evaluation of biomedical literature - clinical pharmacyShaistaSumayya
Reviewing the ‘Biomedical Literature’ poses a great challenge to the clinical professionals.
Evaluating a scientific article is a complex task.
Knowledge of the standard anatomy of an article and idiosyncrasy of various types of studies will assist the reader to review the ‘Biomedical Literature’ efficiently
Biomedical Literature includes critical appraisal of the following contents:
Title
Abstract
Introduction
Objective
Materials and Methods
Study Designs
Bias
Statistics
Results and Analysis
Discussion and Conclusion
References
Home remedies and patient counselling tips for ANEMIA-By rxvichu-alwz4uh!! :) :)RxVichuZ
Hello members....this is my 28th powerpoint..on exactly half of the date(14.09.2017)...lol
This presentation of mine, centralizes on ANEMIA, its introduction, causes, manifestations, and includes GENEROUS DETAILS, on 15 HOME REMEDIES, along with PATIENT COUNSELLING TIPS(DO'S and DONT'S).
This will surely be helpful for those who are studying about ANEMIA, those who indulge in patient counselling, and those who wish to read it for general reference purpose.
I am self-specializing in HOME REMEDY STUDY, and PATIENT COUNSELLING. So, for further details, you can also contact me.
Reviews, suggestions, and critical evaluations, are ALWAYS WELCOME!!
Regards,
Vishnu.R.Nair,
5th year Pharm.D,
National College of Pharmacy, Kerala, India.
In this slides included clinical pharmacy introduction and pharmaceutical care, also explanation about the goals and objectives of the clinical pharmacy requirements
Individualisation and optimization of drug dosing regimenJyoti Nautiyal
Drug dosing regimen, dosing frequency, individualisation, Steps Involved in Individualization of Dosage Regimen, optimization, variability, Clinical experience with individualization and optimization based on plasma drug levels.
Pediatric Drug calculations |drug calculation formulasNEHA MALIK
Most drugs in children are dosed according to body weight (mg/kg) or body surface area (BSA) (mg/m2). Care must be taken to properly convert body weight from pounds to kilograms (1 kg= 2.2 lb) before calculating doses based on body weight. Doses are often expressed as mg/kg/day or mg/kg/dose, therefore orders written "mg/kg/d," which is confusing, require further clarification from the prescriber.
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease. Kevin John
In this presentation, I have tried to explain in brief and precisely about drugs that require renal dose adjustments in Chronic Kidney Disease or Acute Kidney Injury (renal failure).
Clinical pharmacokinetics is the application of pharmacokinetic principles to the safe and effective therapeutic management of drugs in an individual patient. Primary goals of clinical pharmacokinetics include enhancing efficacy and decreasing toxicity of a patient's drug therapy.
The success of drug therapy is highly dependent on the choice of the drug, the drug product, and the design of the dosage regimen. The choice of the drug is generally made by the physician after careful patient diagnosis and physical assessment.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
1. PH2.4
DEMONSTRATE THE CORRECT METHOD
OF CALCULATION OF DRUG DOSAGE IN
PATIENTS INCLUDING THOSE USED IN
SPECIAL SITUATIONS
Dr. Mani Bharti
S.R. Pharmacology
North DMC,Medical College,Delhi
2. Competency: PH 2.4
• Demonstrate the correct method of calculation of drug
dosage in patients including those used in special
situations
Domain
S
Level
S H
Core
(Y)
Suggested
Teaching
Learning method
DOAP sessions
Suggested
Assessment
method
Skills
assessment
Vertical
Integration
Pediatrics,
General
Medicine
3. Learning Objectives
At the end of the teaching learning session, the M.B.B.S Phase II
student shall be able to
• Know the general methods for drug dose calculation.
• Calculate the number of tablets/ quantities of solution or
drip rate for a given condition
• Calculate the doses for various drugs in pediatric
population using appropriate formulae.
• Calculate the doses for various drugs in special situations
(renal/hepatic/heart diseases/obesity) using appropriate
formulae.
• Calculate the loading & maintenance doses.
4. GENERAL METHODS FOR DRUG
CALCULATION
1. BASIC FORMULA
2. RATIO& PROPORTION
3. FRACTIONAL EQUATION
4. BODY WEIGHT
5. BODY SURFACE AREA
5. 1. Basic Formula
• A=D/H X V
• D-desired dose (drug dose ordered by health care
provider)
• H- on-hand (stock on hand/on label of container)
• V- vehicle ( Q- quantity/drug form in which drug comes)
• A- Amount calculated to be given to patient.
6. Examples:
• Avandia 2mg OD. How much tablet will you give?
A=D/HXV
• Solution: 2mg/4 x 1 tablet 4mg = .5 tablet
7. Example
• Paracetamol 500mg. Q 4 hour Round the Clock (RTC)
p.o. The stock on hand is 250mg/5ml in 60ml bottle. How
many ml should be administered?
• D-500 mg, V- 5 ml,H-250mg
• A=D/H X V
A=500/250 X 5= 10 ml
8. 2. Ratio and Proportion
• H : V = D : X
• Where: H = drug on hand (available)
• V = vehicle/drug form (capsule/tablet/liquid)
• D = desired dose (as ordered)
• x = unknown amount to give
9. Example
• Order: Cefdinir (3rd gen cephalosporin) 100 mg PO q.i.d
*How many mL should the patient receive?
• H : V = D : X
• 250:5=100:X
• X=DV/H
• X=100X5/250
• X=2 ML
10. Fractional Equation
• • Same as R & P except it is written as a fraction.
• H/V = D/X
• Example
• Order:Ciprofloxacin 250 mg PO q12h*how many tablets
should the client receive?
• H/V = D/X
• 750/1=250/X
• 1/3 Tab
11. 4. Body Weight (BW)
• Allows individualization of the drug dose
• Involves 3 steps:
1. Convert pounds to kg – 1 Kg = 2.2 lbs
2. 2. Determine drug dose per BW – Drug dose x body
weight = patients dose per day
3. 3. Follow basic formula, R & P
12. Example
• Order: Fluorouracil (5-FU), 12 mg/kg/day IV, not to exceed
800 mg/day. The adult weighs 132 lb.
• 1. Convert pounds to Kg :
• 132/2.2 = 60kg
• 2. mg x kg = patient’s dose: 12 x 60 = 720mg/day
• Answer: fluorouracil 720 mg/day
13. 5. Body Surface Area (BSA)
Most accurate to calculate drug dose for:
– Infants
– Children
– Older adults
– patients who are on antineoplastic agents
– low body weight
BSA is expressed as square meters (m2).
It can be determined using: -
Equations (e.g., Mosteller Method, Du Bois Method) –
Nomograms
- An average-sized adult has a BSA of 1.73 m2
16. nomogram
• A nomogram has three columns:
• - Height (expressed in centimeters and in inches)
• - Body surface area (expressed in square meters)
• - Weight (expressed in kilograms and in pounds)
• - To use a nomogram, the height and weight of a patient
are found on the nomogram and then a straight line is
drawn connecting the two values.
• - The BSA for that patient is found where the line
intersects the BSA column.
17. Example
• Order:Cyclophosphamide (Cytoxan) 100 mg/m2/day,
• IV; available dosage is 200mg; patient’s height is 70
inches, weight is 160 lbs.
• 1. 70 inches and 160 lbs intersect the nomogram scale at
1.97 m2 (BSA).
• 2. 100 mg x 1.97 = 197mgAnswer:Administer
cyclophosphamide 197 mg/day
20. IV Drip Rate Calculation:
Drop factor of tubing:
• Macrodrip = 10, 15, or 20 gtt/mL
• Microdrip = 60 gtt/mL
• The drop factor of the tubing is found on the tubing box.
For calculations, it must be stated in the problem.
21. Example
A patient is to receive 1 L of Hartmann’s solution over the
next 12 hours. What is the rate of infusion in drops per
minute (dpm), if the drop factor is 60 drops per mL .
Solution: Volume = 1 000 mL, since 1 L = 1 000 mL.
Time = 12 hours.
Drop Factor = 60 drops per mL.
Substituting these values into the drip rate formula gives:
Drip Rate (dpm) = 1 000ml/ 12 hr × 60 drops/ml/60 min/ h
= 83.833 ≈ 84 drops/minutes .
22. Drug dosing in special populations
• A special population are persons displaying one or more
of the following characteristics:
• a. prone to under or over responding to usual dosing
regimens
• b. least able to tolerate, recognize, or communicate drug
effects
• c. accidentally frequently mis‐dose
23. Patient conditions that may altered the
dosing of most drugs
• • Renal or hepatic disease,.
• • Dialysis procedures
• • Heart failure
• • Obesity
• • Age.
24. Renal Disease
Two important equatation are there for calculation of drug
dose in renal disease patients
Cockcroft-gault
MDRD(eGFR)
• The most common method of estimating glomerular
filtration for the purpose of drug dosing is to measure
/estimate Creatinine Clearance CrCl(ml/min)
25. MDRD equation
eGFR is estimated GFR calculated by the abbreviated MDRD equation :
186 x (Creatinine/88.4)-1.154 x (Age)-0.203 x (0.742 if female) x (1.210 if black).
26.
27. Modifying Doses for patients with renal
impairment
• It is possible to decrease the drug dose
and retain the usual dosage interval, or
• Retain the usual dose and increase the
dosage interval, or
• Both decrease the dosage and prolong
the dosage interval
• The choice was made depend on the
route of drug administration, the dosage
forms available
28. St
Stageg GFR* Description
1 90+
Normal kidney function but urine findings or structural
abnormalities or genetic trait point to kidney disease
2 60-89
Mildly reduced kidney function, and other findings (as for
stage 1) point to kidney disease
3A
3B
45-59
30-44
Moderately reduced kidney function
4 15-29 Severely reduced kidney function
5
<15 or on
dialysis Very severe, or end-stage kidney failure
29. For drugs with narrow therapeutic index
• Measured or estimated CrCl may be used to
estimate pharmacokinetic parameters for a patient
based on prior studies conducted in other patients
with renal dysfunction
• Estimated pharmacokinetic parameters are then
used in pharmacokinetic dosing equation to
compute initial dose
30. Hepatic Disorders
• Most lipid soluble drugs are metabolized to some
degree by the liver
Two major types of liver disease
1. Hepatitis ‐ Acute hepatitis: mild, transient
decreases in drug metabolism required no or minor
changes in drug dosing ‐ Chronic hepatitis:
irreversible hepatocytes damage required drug
dosage changes. Patients with long term
hepatocytes damage can progress to hepatic
cirrhosis
2. Cirrhosis; a permanent lost of functional
hepatocytes. Drug dosage schedules usually need
to be modified
31.
32. Heart Failure
• Is accompanied by a decrease in cardiac output
results in lower liver and renal blood flow
• Decreased drug bioavailability has been
reported, due to collection of edema fluid in the GI
tract difficult absorption and decreased blood flow
to GI tract
33. Obesity
• Estimating the optimal dose for obese patients
is difficult and, in many cases, ill defined.
• Basing maintenance doses on total body
weight is unlikely to result in a comparable
drug response across different body sizes and
generally increases the risk of adverse events.
Individualised
• dosing based on the patient’s lean body
weight is recommended, with accompanying
therapeutic drug monitoring and monitoring of
the patient’s clinical response
• .
34. Body size descriptors commonly used in
drug dosing
Name Formula
Total body weight (kg) –
Ideal body weight (kg)
13
45.4 + 0.89 x (height (cm) – 152.4) +
(4.5 if male)
Adjusted body weight (kg) Correction factor* x (TBW – IBW) +
IBW
Lean body weight (kg)
males 9270 x TBW (kg)6680+216 x BMI (kg/
m2)
Females 9270 x TBW (kg)6680+244 x BMI (kg/
m2)
35. Age
Children are not small adults but rather distinct
individuals who have different absorption,
distribution, metabolism, and excretion rates of
medications than adults.
36. Pediatric considerations
• Fried’s rule –
• applies to the child younger than 1 year of age.
• Infant dose=
• infant age (months) X adult average dose/ 150
38. Clark’s Rule
• One of the most popular methods for determining
medication dosages for children.
• Based upon a child’s body weight and the assumption that
the average normal adult weighs 150 pounds.
• Ratio proportions are used in this method.
• Clark’s rule should be used if no other formula is
specified.
39.
40. Loading doses
Loading doses are useful for drugs that are eliminated from the
body relatively slowly
• Such drugs need only a low maintenance dose in order to
keep the
amount of the drug in the body at the target level
• Without loading, it would take longer for the amount of the
drug to
reach target level
• Loading doses typically are adjusted based on Vd and are
not adjusted
for renal failure
•If extracellular volume depletion is present, Vd may be
reduced and
reductions in loading dose should occur
41. Three variables are used to calculate the loading dose:
• Cp = desired peak concentration of drug
• Vd = volume of distribution of drug in body
• F = bioavailability
•The required loading dose may then be calculated as:
Loading dose = Cp x Vd x Ideal body weight/F
•For an intravenously administered drug, the bioavailability F
will equal 1, since the drug is directly introduced to the
bloodstream.
If the patient requires an oral dose, bioavailability will be less
than 1 (depending upon absorption, first-pass metabolism,
etc.),
requiring a larger loading dose
42. Drug Dosing–Maintenance Dose
• Maintenance doses ensure steady-state blood
concentrations and lessen the likelihood of sub-therapeutic
regimens or overdoses
•In the absence of a loading dose, maintenance doses will
achieve 90% of their steady-state level in 3–4½ lives
•Two options for ESRD
• Reduce the dose
• Lengthen the interval between doses (more useful for a
drug with a wide therapeutic range and long half-life)
• Maintenance dose can be calculated the same way as
loading dose
43. Conversions:
• 1 liter (L) = 1000 ml (milliters)
• 1 gram (g) = 1000 mgs (milligrams)
• 1 mg (milligrams) = 1000 mcgs (micrograms)
• 1 gram (g) = 15 grain (gr)
• 1 grain (gr) = 60 mg (milligrams)
• 1 dram (dr) =4 ml (milliters)
• 1 ounce (oz) = 30 ml (milliters)
• 1 tsp (teaspoon) = 5 ml (milliters)
• 1 tbs (tablespoon) = 15 ml (milliters)
• 1 kg (kilogram) = 2.2 lbs (pounds)
• 1 inch = 2.54 cm (centimeters)
• 16 ounces (ozs) = 1 lb (pound)
• 1 cup = 8 ounces (ozs)
1 ml (milliter) = 15 minims
• 1 tsp (teaspoon) = 5 ml (milliters)
• 1 tbs (tablespoon) = 15 ml (milliters)
• 1 drop (gtt) = 15 minims
44. Q. The normal adult doses of medication
is 150 mg you have a child that weighs
30 kg and is 1.2 meter in height. How
much medication will you give to the
child?
45. Answer
• Calculate BSA= 30kg x120cm/3600 =1 , now child
dosage= BSA x ADULT DOSE / 1.7M2 = 88.24mg
46. Q. A pediatric patient is to receive
Atropine 0.02 mg/kg,the patient weight
is 10 kg,what is the Desired Dose?
48. Q. Calculate the dose of Amoxicillin for 8 yr old girl using
young’s formula ,when the adult dose of capsule
Amoxicillin is 250 mg TDS ?
49. • Youngs Formula = (Age/Age+12 )*Adult Dose so
(8/8+12)*250 = 100mg
Answer
50. Q. Calculate the dose of Amoxicillin for 8 yr old girl using
young’s formula ,when the adult dose of capsule
Amoxicillin is 250 mg TDS ?
51. • Youngs Formula = (Age/Age+12 )*Adult Dose so
(8/8+12)*250 = 100mg
Answer
52. Q. Find out the dose of cephalexin
using Dilling’s formula for a 2 yr
old child when the adult dose is
500 mg TDS?
53. • Dillings formula ={( Age / 20) *Adult Dose } , So 2/20 *500
= 50 mg
Answer
54. •Find out the dose of a drug X for a
3 yr old child by Dilling formula as
well as young formula when adult
dose of that drug is 650 mg TDS.
55. • Dilling formula = Age/20 *Adult dose , So here Dose =
4/20*500mg=100mg
Answer
56. • Calculate the daily dose of Amikacin for 75 years old
female obese patient weight 90 kg having S. creatinine –
2.5 mg/dl suffering from renal parenchyma disease.
57. • Creatinine clearance in renal insufficiency = ( 140 - Age ) *
Weight ( kg ) multipy 0.85 ( If females) /72 * S.
Creatinine ( mg / ml )
• 140-75 *90*0.85*100/72*2.5 =2.763gm.